We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Research on familial heart disease is carried out, for the most part, through the Institut d'Investigacions Biomèdiques August Pi i Sunyer in the Area of Biopathology and respiratory, cardiovascular and renal bioengineering. The groups that develop this research are:
Arrhythmias, resynchronization and cardiac imaging
The projects that are underway in the field of familial heart disease are:
ANVERSO: Continuous and Automatic analysis of Electrocardiographic Variables associated to the Risk of Sudden Death in patients with Brugada Syndrome. FIS Project
MOSCAT Study (Sudden Death in Catalonia). Collaboration between the Cardiovascular Genetics Centre, the High Court of Justice of Catalonia, the Institute of Legal Medicine and Forensic Sciences of Catalonia and Hospital Josep Trueta in Girona, Hospital Clínic in Barcelona and Hospital Sant Joan de Déu in Barcelona.
B3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure: Placebo-Controlled Phase II Randomized Clinical Trial. Project of La Marató de TV3.
Study of the pathophysiological mechanisms that lead to right ventricular maladaptive hypertrophy in chronic pulmonary hypertension. FIS project.
There is also a clinical trial underway:
ARRAY Study. A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 in Patients with Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation.
Sorry this content wasn't helpful to you. Send us your comment and we will take it into account to continue improving.
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.